6.83
Precedente Chiudi:
$6.51
Aprire:
$6.57
Volume 24 ore:
26,062
Relative Volume:
0.12
Capitalizzazione di mercato:
$54.34M
Reddito:
$49.09M
Utile/perdita netta:
$-52.15M
Rapporto P/E:
-10.51
EPS:
-0.65
Flusso di cassa netto:
$-45.93M
1 W Prestazione:
-14.62%
1M Prestazione:
+0.00%
6M Prestazione:
-13.57%
1 anno Prestazione:
-71.54%
Biodesix Inc Stock (BDSX) Company Profile
Nome
Biodesix Inc
Settore
Industria
Telefono
303-417-0500
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Confronta BDSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BDSX
Biodesix Inc
|
6.83 | 51.79M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-26 | Iniziato | Craig Hallum | Buy |
| 2024-05-13 | Iniziato | TD Cowen | Buy |
| 2024-05-03 | Iniziato | Lake Street | Buy |
| 2021-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Iniziato | BTIG Research | Buy |
| 2020-11-23 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-23 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-23 | Iniziato | William Blair | Outperform |
Mostra tutto
Biodesix Inc Borsa (BDSX) Ultime notizie
Is Biodesix Inc. stock attractive for hedge fundsMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
What drives Biodesix Inc stock priceEconomic Indicators Overview & Rapid Wealth Building Tips - earlytimes.in
Is Biodesix Inc. a candidate for recovery playJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Advanced analytics toolkit walkthrough for Biodesix Inc.2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Top chart patterns to watch in Biodesix Inc.Quarterly Market Summary & Reliable Breakout Forecasts - newser.com
Is Biodesix Inc. stock a bargain at current levelsWeekly Market Summary & Stock Market Timing Techniques - newser.com
Biodesix Inc. recovery potential after sell offJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays - MSN
Is Biodesix Inc. stock a good choice for value investorsPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Biodesix Inc. stock a defensive play in 2025Portfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Can Biodesix Inc. stock rebound after recent weakness2025 Trading Recap & Reliable Breakout Forecasts - newser.com
What momentum indicators show for Biodesix Inc. stockMarket Rally & Growth Oriented Trade Recommendations - newser.com
How risky is Biodesix Inc. stock now2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Biodesix (NASDAQ:BDSX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Biodesix Inc (BDSX) Stock Price, Trades & News - GuruFocus
Best data tools to analyze Biodesix Inc. stock2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Can Biodesix Inc. stock outperform in 2025 bull marketDay Trade & Real-Time Market Trend Scan - newser.com
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth - TipRanks
Biodesix Inc Azioni (BDSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biodesix Inc Azioni (BDSX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pestano Gary Anthony | Chief Development Officer |
Nov 10 '25 |
Sale |
7.62 |
23 |
175 |
7,939 |
| O'Kane Kieran | Chief Commercial Officer |
Nov 10 '25 |
Sale |
7.62 |
25 |
190 |
7,362 |
| Hutton Scott | President & CEO |
Nov 10 '25 |
Sale |
7.62 |
189 |
1,440 |
37,311 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Nov 10 '25 |
Sale |
7.62 |
50 |
381 |
13,147 |
| SCHULER JACK W | Director |
Sep 19 '25 |
Buy |
7.04 |
142,045 |
999,997 |
1,380,745 |
| SCHULER JACK W | Director |
Sep 17 '25 |
Buy |
6.04 |
15,317 |
92,571 |
1,235,644 |
| SCHULER JACK W | Director |
Sep 18 '25 |
Buy |
6.17 |
3,056 |
18,854 |
1,238,700 |
| SCHULER JACK W | Director |
Aug 29 '25 |
Buy |
0.43 |
3,488,372 |
1,500,000 |
24,406,546 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Aug 13 '25 |
Sale |
0.42 |
988 |
411 |
250,794 |
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):